- Home
- MCRB vs VFL Comparison
MCRB vs VFL Comparison
Compare MCRB & VFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- VFL
- Stock Information
- Founded
- MCRB 2010
- VFL 1993
- Country
- MCRB United States
- VFL United States
- Employees
- MCRB N/A
- VFL N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- VFL Finance/Investors Services
- Sector
- MCRB Health Care
- VFL Finance
- Exchange
- MCRB Nasdaq
- VFL Nasdaq
- Market Cap
- MCRB 144.6M
- VFL 116.3M
- IPO Year
- MCRB 2015
- VFL N/A
- Fundamental
- Price
- MCRB $20.47
- VFL $10.24
- Analyst Decision
- MCRB Hold
- VFL
- Analyst Count
- MCRB 4
- VFL 0
- Target Price
- MCRB $14.33
- VFL N/A
- AVG Volume (30 Days)
- MCRB 227.9K
- VFL 38.0K
- Earning Date
- MCRB 11-12-2025
- VFL 01-01-0001
- Dividend Yield
- MCRB N/A
- VFL 4.16%
- EPS Growth
- MCRB N/A
- VFL N/A
- EPS
- MCRB 10.22
- VFL N/A
- Revenue
- MCRB N/A
- VFL N/A
- Revenue This Year
- MCRB N/A
- VFL N/A
- Revenue Next Year
- MCRB N/A
- VFL N/A
- P/E Ratio
- MCRB $2.05
- VFL N/A
- Revenue Growth
- MCRB N/A
- VFL N/A
- 52 Week Low
- MCRB $6.53
- VFL $7.93
- 52 Week High
- MCRB $24.67
- VFL $10.77
- Technical
- Relative Strength Index (RSI)
- MCRB 60.09
- VFL 59.09
- Support Level
- MCRB $19.14
- VFL $10.12
- Resistance Level
- MCRB $21.97
- VFL $10.34
- Average True Range (ATR)
- MCRB 1.52
- VFL 0.09
- MACD
- MCRB 0.22
- VFL -0.03
- Stochastic Oscillator
- MCRB 80.36
- VFL 41.50
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About VFL abrdn National Municipal Income Fund
Delaware Investments Natl Muni Income is a closed-end investment fund. The Fund seeks to provide current income exempt from regular federal income tax consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, Delaware Funds by Macquarie Premier Models, Managed accounts, Closed-end funds, and Variable Insurance Products.